SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit PAb, Antigen Affinity Purified (40591-T62)

SARS-CoV-2 (2019-nCoV) Spike抗体, Rabbit PAb, Antigen Affinity Purified

应用:WB, ELISA
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
WB1:1000-1:5000
ELISA1:5000-1:10000

应用说明

IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant SARS-CoV-2 (2019-nCoV) Spike S-His Protein (Catalog#40591-V08H)
宿主/亚型Polyclonal Rabbit IgG
抗体类型Polyclonal
产品类型Antibody
克隆号Polyclonal Rabbit IgG
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A & Antigen Affinity
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
RRIDAB_2893171

特异性

SARS-CoV-2 Spike S1 Has cross-reactivity in ELISA and WB with SARS-CoV-2 (2019-nCoV) Spike RBD-mFc Protein (Catalog#40592-V05H) SARS-CoV Spike S1-His Protein (Catalog#40150-V08B1) SARS-CoV Spike RBD-His Protein (Catalog#40150-V08B2)

制备方法

Produced in rabbits immunized with purified, recombinant SARS-CoV-2 (2019-nCoV) Spike S1-His Recombiant Protein (HPLC-verified) (Catalog#40591-V08H; YP_009724390.1; Val16-Arg685). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Spike affinity chromatography.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2 (angiotensin-converting enzyme 2), DPP4 (dipeptidyl peptidase-4), APN (aminopeptidase N), CEACAM (carcinoembryonic antigen-related cell adhesion molecule), Sia (sialic acid), O-ac Sia (O-acetylated sialic acid). The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate. References Shen S, et al . (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35. Du L, et al . (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36. Xiao X, et al . (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.

文献引用 (62)

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base

超强效SARS冠状病毒中和单域抗体,可阻断其刺突蛋白的基部。

Sieglinde De Cae ,Inge Van Molle ,Loes van Schie ,Sophie R Shoemaker ,Julie Deckers ,Nincy Debeuf ,Sahine Lameire ,Wim Nerinckx ,Kenny Roose ,Daria Fijalkowska ,Simon Devos ,Anne-Sophie De Smet ,Jackeline Cecilia Zavala Marchan ,Toon Venneman ,Koen Sedeyn ,Lejla Mujanovic ,Marlies Ballegeer ,Manon Vanheerswynghels ,Caroline De Wolf ,Hans Demol ,Jasper Zuallaert ,Pieter Vanhaverbeke ,Gholamreza Hassanzadeh Ghassabeh ,Chiara Lonigro ,Viki Bockstal ,Manuela Rinaldi ,Rana Abdelnabi ,Johan Neyts ,Susan Marqusee ,Bart N Lambrecht ,Nico Callewaert ,Han Remaut ,Xavier Saelens ,Bert Schepens

Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates.

mRNA SARS-CoV-2 变异疫苗在非人灵长类动物中的保护效力

Yi Dongrong, Zhang Yongxin, Wang Jing, Liu Qian, Ma Ling, Li Quanjie, Guo Saisai, Zheng Ruifang, Li Xiaoyu, Li Xingong, Dong Yijie, Lu Shuaiyao, Zhang Weiguo, Peng Xiaozhong, Cen Shan

DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication

DAZAP2 通过抑制病毒进入和基因组复制,发挥泛冠状病毒限制因子的作用。

Fei Feng # ,Jiannan Chen # ,Rong Li # ,Yunkai Zhu # ,Yanlong Ma ,Ziqiao Wang ,Yuyan Wang ,Zhichao Gao ,Lulu Yang ,Yin Yu ,Yanfeng Liu ,Yingjie Sun ,Ying Liao ,Xinxin Huang ,Qisheng Zhang ,Yongheng Huang ,Lin Qiu ,Jiayu Wu ,Jingxian Zhao ,Chao Liu ,Qiang Ding ,Youhua Xie ,Zhenghong Yuan ,Yue Hong ,Ping Zhang ,Jing Sun ,Jincun Zhao ,Rong Zhang

Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.

糖基磷脂酰肌醇生物合成通过调节 LY6E 发挥保守的宿主防御途径对抗冠状病毒的作用

Ma Yanlong, Feng Fei, Feng Hui, Ma Xue, Wang Ziqiao, Han Yutong, Zhu Yunkai, Wang Yuyan, Gao Zhichao, Zhang Yuyuan, Ding Qiang, Zhao Jincun, Zhang Rong

Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.

对 SARS-CoV-2 亚型 BA.2.86、JN.1、KP.2 和 KP.3 的复制和免疫逃避进行比较分析

Hu Yanping, Zou Jing, Nguyen Michael D, Chang Hope C, Yeung Jason, Hao Haiping, Shi Pei-Yong, Ren Ping, Xie Xuping

Immune factors produced by PBMCs upon stimulation with lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1-derived exopolysaccharides inhibit HCoV-229E and SARS-CoV-2 replication.

用保加利亚乳杆菌 OLL1073R-1 衍生的胞外多糖刺激 PBMC 产生的免疫因子可抑制 HCoV-229E 和 SARS-CoV-2 的复制

Tang Shuyi, Takai-Todaka Reiko, Ishii Shoko, Kono Hiroki, Watanabe Reiko, Ogawa Miho, Kano Hiroshi, Katayama Kazuhiko, Sashihara Toshihiro, Hojo Kenichi, Haga Kei

PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.

PLSCR1 通过下调细胞表面 ACE2 来抑制 SARS-CoV-2 感染

Ma Ruiyi, Zhang Xinyi, Li Ruonan, Dong Xiaojing, Wang Wenjing, Jiang Qi, Xiao Xia, Shi Yujin, Chen Lan, Zheng Tian, Xiang Zichun, Ren Lili, Zhou Zhuo, Lei Xiaobo, Wang Jianwei

Natural evidence of coronaviral 2'-O-methyltransferase activity affecting viral pathogenesis via improved substrate RNA binding.

冠状病毒 2'-O-甲基转移酶活性通过改善底物 RNA 结合影响病毒致病性的自然证据

Deng Jikai, Yang Shimin, Li Yingjian, Tan Xue, Liu Jiejie, Yu Yanying, Ding Qiang, Fan Chengpeng, Wang Hongyun, Chen Xianyin, Liu Qianyun, Guo Xiao, Gong Feiyu, Zhou Li, Chen Yu

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants

SARS-CoV-2 BA.2.86 和 FLip 变体的免疫逃避、感染性和融合性

Panke Qu ,Kai Xu ,Julia N Faraone ,Negin Goodarzi ,Yi-Min Zheng ,Claire Carlin ,Joseph S Bednash ,Jeffrey C Horowitz ,Rama K Mallampalli ,Linda J Saif ,Eugene M Oltz ,Daniel Jones ,Richard J Gumina ,Shan-Lu Liu

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3

SARS-CoV-2 BA.2.86/JN.1 和 EG.5.1/HK.3 的谱系特异性致病性、免疫逃避和病毒学特征

Yuanchen Liu #, Xiaoyu Zhao #, Jialu Shi #, Yajie Wang #, Huan Liu #, Ye-Fan Hu #, Bingjie Hu, Huiping Shuai, Terrence Tsz-Tai Yuen, Yue Chai, Feifei Liu, Hua-Rui Gong, Jiayan Li, Xun Wang, Shujun Jiang, Xiang Zhang, Yanliang Zhang, Xiangnan Li, Lei Wang, Madeline Hartnoll, Tianrenzheng Zhu, Yuxin H
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7